Cargando…
Automated tumor proportion score analysis for PD-L1 (22C3) expression in lung squamous cell carcinoma
Programmed cell death ligend-1 (PD-L1) expression by immunohistochemistry (IHC) assays is a predictive marker of anti-PD-1/PD-L1 therapy response. With the popularity of anti-PD-1/PD-L1 inhibitor drugs, quantitative assessment of PD-L1 expression becomes a new labor for pathologists. Manually counti...
Autores principales: | Liu, Jingxin, Zheng, Qiang, Mu, Xiao, Zuo, Yanfei, Xu, Bo, Jin, Yan, Wang, Yue, Tian, Hua, Yang, Yongguo, Xue, Qianqian, Huang, Ziling, Chen, Lijun, Gu, Bin, Hou, Xianxu, Shen, Linlin, Guo, Yan, Li, Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342621/ https://www.ncbi.nlm.nih.gov/pubmed/34354151 http://dx.doi.org/10.1038/s41598-021-95372-1 |
Ejemplares similares
-
Automated tumor proportion scoring for PD-L1 expression based on multistage ensemble strategy in non-small cell lung cancer
por: Pan, Boju, et al.
Publicado: (2021) -
Automated PD-L1 Scoring Using Artificial Intelligence in Head and Neck Squamous Cell Carcinoma
por: Puladi, Behrus, et al.
Publicado: (2021) -
Semi-automated testing of proportional counters
por: Sangwine, S J
Publicado: (1980) -
Deep Semi Supervised Generative Learning for Automated Tumor Proportion Scoring on NSCLC Tissue Needle Biopsies
por: Kapil, Ansh, et al.
Publicado: (2018) -
Reproducibility in PD-L1 Immunohistochemistry Quantification through the Tumor Proportion Score and the Combined Positive Score: Could Dual Immunostaining Help Pathologists?
por: Mercier, Anaïs, et al.
Publicado: (2023)